EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Cohen Dev (CDEV) fair value: what the stock is really worth

As of Oct 8, 2026: fair value of Cohen Dev ILS 159, price ILS 145, upside +9.3%, quality 60 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Industrials · Il · ISIN IL0008100104

CD Broad data Oct 3, 2026

Cohen Dev

CDEV · TA

NeutralThe stock looks roughly fairly valued with average quality.

Quality 60/100
Healthy Growth (revenue 5y +17.4 %/yr in ILA)
Highly profitable · 94.0% net margin (TTM)
Low debt
Generates free cash flow
Ranks above peers (10/14)
Broad data
Fair value 158.87 ILA · Fairly valued (+9.3%)
Wide moat 91/100 · thin data
⚠ Dilution

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

222.32 ILA 44.13 ILA Fair Value 158.87 ILA May 2021 Oct 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 3, 2026.

How to read this chart

60‑month range 44.13 ILA – 222.32 ILA · fair‑value band 96.14 ILA – 243.02 ILA · the 145.30 ILA price screens below the 158.87 ILA fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Oct 3, 2026.

Follow Cohen Dev in your weekly email

Every Wednesday you see whether Cohen Dev is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Cohen Development Gas & Oil Ltd. engages in exploration, development, production and marketing of oil, natural gas, and condensate in Israel, Cyprus, Morocco, and Bulgaria. The company was incorporated in 1958 and is based in Bnei Brak, Israel.

Stock analysis

Cohen Dev (CDEV) currently trades at 145.30 ILA, while our model-based Fair Value estimate is 158.87 ILA, so the stock looks roughly fairly valued today (gap 8.5%).

Show more

Valuation

Bull case: the DCF Models group reads highest at a median of 238.93 ILA per share, and 6 of the 11 models we run sit above the 145.30 ILA price.

Bear case: the Asset-Based group reads lowest at 19.61 ILA, and 5 of the 11 models stay below the price. Evidence for this calculation is high.

Scenario range: 96.14 ILA (bear) to 243.02 ILA (bull), the price of 145.30 ILA sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 60/100 (solid quality), in the Industrials sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

Cohen Dev reported revenue of $30.0M in FY2025 versus $16.5M in FY2021, a compound +16.1%/yr. Reported net income was $34.3M in FY2025, compounding +20.0%/yr from FY2021.

Key figures

Market cap 1.1B ILA · P/E ratio 11.4 · P/S ratio 13.1 · EPS (TTM) 12.73 ILA · Dividend yield 2.2% · Net margin 115% · Return on equity 52.7% · Return on assets (EBIT) 65.3%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).

What moves the price

The share trades about 35% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Industrials peers we cover trades at −16% fair-value upside, at 9%, CDEV screens cheaper than that median.

Fair Value models

Bear 96.14 ILA Fair Value 158.87 ILA Bull 243.02 ILA
Price 145.30 ILA · Upside +9.3%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (7.40 ILS per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
Growth DCF 118.75 ILA 201.36 ILA 314.82 ILA 77
Residual Income 76.76 ILA 102.73 ILA 204.57 ILA 71
5Y P/E Exit 145.61 ILA 266.89 ILA 413.55 ILA 69
All 11 models by family
DCF Models
5Y P/E Exit 145.61 ILA 266.89 ILA 413.55 ILA 69
10Y P/E Exit 135.22 ILA 238.93 ILA 399.61 ILA 62
Earnings-Based
Graham-Dodd 100.24 ILA 574.22 ILA 798.45 ILA 63
Lynch FV 161.69 ILA 230.99 ILA 300.28 ILA 61
Dividend Discount
Gordon GGM 77.60 ILA 139.83 ILA 192.49 ILA 68
DDM Multi-Stage 77.60 ILA 127.73 ILA 149.37 ILA 67
Multiples
P/E Multiple 154.78 ILA 206.37 ILA 257.96 ILA 63
P/B Multiple 39.50 ILA 52.67 ILA 65.84 ILA 55
Asset-Based
NCAV (Graham) 14.63 ILA 19.61 ILA 29.26 ILA 54
Growth DCF
Growth DCF 118.75 ILA 201.36 ILA 314.82 ILA 77
Economic Profit
Residual Income 76.76 ILA 102.73 ILA 204.57 ILA 71

Open the full fair value analysis →

Quality Score breakdown

Overall quality 60/100

Of which business quality 62 · Market factors (momentum, volatility) 35

Profitability 79
Margins and returns on capital today
Quality Growth 22
Are margins and returns improving?
Cashflow 77
Earnings quality: real cash, not paper profit
Fin. Strength 100
Balance sheet, leverage, solvency risk
Investment 33
Disciplined investing over empire-building
Low Volatility 80
Calm price path (market factor)
Momentum 24
Price trend over the last 3–12 months (market factor)
52W Momentum 3
Distance to the 52-week high (market factor)
Net Issuance 21
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 100/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Revenue growth 1 year
+2.1%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+17.4%
Start year 2020 (pandemic). Over 10 years: +16.7% a year
Revenue growth 18 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+5.2%
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Basis: EBIT basis.
≈ +27.5%
Earnings growth per share plus dividend.
Earnings per share, growth per year+25.3%
Dividend (yield on the price)2.2%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.37.3% vs 21.7%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.55% → 85%
Pace: the 5-year rate starts in 2020 (pandemic)
⚠ Rate on operating basis: 2025 sits 56% above its own trend.

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+30.9%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Israel: IMF forecast 2.1% a year to 2030, 1.7% from 2016 to 2025) that is about +28.2% a year for the price.

Watch CDEV, get fair value alerts →

Compare Cohen Dev with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Conglomerates · 359 stocks

Beats the industry median on 10/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 60 · Top 25%
Fair Value upside +9.3% · Above median
Profitability
Return on equity (TTM) 52.7% · Top 25%
Return on assets 27.1% · Top 25%
Net margin (TTM) 94.0% · Top 25%
Operating margin (TTM) 87.8% · Top 25%
Growth and dividend
Revenue growth 70.0% · Top 25%
Dividend yield (TTM) 2.2% · Above median
Balance sheet
Debt / equity 0.04× · Below median

Valuation Multiplesvs Conglomerates median · lower = cheaper

P/E (TTM) 11.4× · Cheaper than median
P/B 5.05× · Priciest 25%
P/S (TTM) 11.45× · Priciest 25%
P/FCF 15.7× · Pricier than median
EV/EBITDA 11.9× · Pricier than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)46 · sector 42
FUTURE (revenue growth)100 · sector 24
PAST (return on equity)100 · sector 22
HEALTH (low debt)98 · sector 90
DIVIDEND (yield)44 · sector 44

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Conglomerates stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
CITIC Limited 0267 HK$12.94 HK$25.88 +100% vs CDEV
Jardine Matheson Holdings J36 $56.73 $78.34 +38% vs CDEV
Honeywell International Inc HON $214.14 $244.82 +14% vs CDEV
Kingdom Holding 4280 13.08 SAR 13.40 SAR +2% vs CDEV
Koç Holding KCHOL 216.50 TRY 182.26 TRY −16% vs CDEV
Aker ASA AKER kr 1,360 kr 1,017 −25% vs CDEV
SK Inc 034730 611,000 KRW 348,688 KRW −43% vs CDEV
3M Company MMM $163.64 $72.78 −56% vs CDEV
Keppel Ltd BN4 11.30 SGD 3.88 SGD −66% vs CDEV
Swire Pacific Limited 0019 HK$102.00 HK$28.34 −72% vs CDEV

Explore undervalued stocks

More undervalued Industrials stocks →

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Cohen Dev Fair Value". https://www.fairvalue-calculator.com/stock/CDEV

Frequently asked questions

Is Cohen Dev (CDEV) overvalued or undervalued?
As of Oct 3, 2026, our model estimates a fair value of 158.87 ILA versus a price of 145.30 ILA, about +9% upside (fairly valued).
What is the fair value of CDEV?
Our model-based fair value for Cohen Dev is 158.87 ILA (as of Oct 3, 2026), built from audited fundamentals. The current price: 145.30 ILA.
What is the quality score of CDEV?
Cohen Dev has a Quality Score of 60/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Cohen Dev (CDEV)?
Our model-based price target is the fair value of 158.87 ILA (as of Oct 3, 2026) from 11 valuation models. Cautious scenario 96.14 ILA, optimistic scenario 243.02 ILA. It is a calculation from audited fundamentals, not an analyst target.
What is the Cohen Dev stock forecast for 2026?
Our models put fair value at 158.87 ILA, about +9% upside versus a price of 145.30 ILA (fairly valued). Cautious scenario 96.14 ILA, optimistic scenario 243.02 ILA. The calculation is refreshed regularly with new filings.
What is the revenue of Cohen Dev (CDEV)?
Cohen Dev reported trailing-twelve-month revenue of about 30.1M ILS (latest available figure, as of Oct 3, 2026).
Does Cohen Dev pay a dividend?
Cohen Dev currently shows a dividend yield of about 2.21% relative to its recent price (as of Oct 3, 2026).
What growth is priced into Cohen Dev (CDEV)?
For today's price to be fair in a discounted-cash-flow model, Cohen Dev would have to grow free cash flow by +30.9 % per year for five years (discount rate 11.6 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +17.4 % per year. As of Oct 3, 2026.
What discount rate (WACC) does the fair value of CDEV use?
Our models discount Cohen Dev at 11.6 %: a base by market capitalisation (small), damped by beta 0.11, country premium for Israel. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Cohen Dev that is +30.9 % per year a year over ten years, using the same discount rate (11.6 %) and the same formula as our fair value.
How much growth has Cohen Dev (CDEV) delivered so far?
Over the past 5 years revenue at Cohen Dev grew +17.4 % a year. The price currently implies +30.9 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Cohen Dev (CDEV) growing?
The median revenue growth in the sector is +11.1 % a year. That is the yardstick for the growth priced into Cohen Dev (+30.9 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Cohen Dev (CDEV)?
The free-cash-flow yield on the price is 2.08 %: that much free cash flow Cohen Dev produces per unit of market value. When it exceeds the discount rate of our models (11.6 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Cohen Dev (CDEV)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Cohen Dev it is 158.87 ILA per share (as of Oct 3, 2026), against a price of 145.30 ILA. It is the blended result of 11 valuation models (cash flow, earnings, asset, dividend).
Is Cohen Dev stock overvalued or undervalued in 2026?
As of Oct 3, 2026, CDEV trades below its calculated fair value: price 145.30 ILA, fair value 158.87 ILA, a gap of about +9% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of CDEV?
No. The price is what the market pays today (145.30 ILA); the fair value is what the company's own numbers justify (158.87 ILA). For Cohen Dev the two are 13.57 ILA per share apart. That gap is exactly why we show both numbers side by side.
How much is Cohen Dev worth?
The market values Cohen Dev at about 1.1B ILA (market capitalisation, as of Oct 3, 2026). Per share that is 145.30 ILA; our models calculate a fair value of 158.87 ILA per share.
What do the bullish and bearish scenarios say about CDEV?
Our models span a range for Cohen Dev: cautious scenario 96.14 ILA, base 158.87 ILA, optimistic 243.02 ILA per share (as of Oct 3, 2026, price 145.30 ILA). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of CDEV?
Cohen Dev trades at a price-to-earnings ratio of 11.4 (as of Oct 3, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 158.87 ILA is built from several models across several years. Other multiples: P/B 5.1, P/S 11.4, EV/EBITDA 11.9.
How solid is the balance sheet of Cohen Dev (CDEV)?
Balance-sheet figures for Cohen Dev (as of Oct 3, 2026): return on equity 52.7%, debt of 0.04 per unit of equity. They feed the Quality Score of 60/100, which measures business quality independently of the share price.
How far is CDEV from its 52-week high?
Cohen Dev trades at 145.30 ILA, about 35% below its 52-week high of 222.32 ILA and at the low of 145.00 ILA (as of Oct 8, 2026). Distance from the high says nothing about value: that is what the fair value of 158.87 ILA is for.
Which stocks are comparable to Cohen Dev?
From the same area (Industrials) we also value 3M Company, Honeywell International Inc, CITIC Limited, Swire Pacific Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Cohen Dev stock attractive at the current price?
The data as of Oct 3, 2026: price 145.30 ILA, calculated fair value 158.87 ILA (+9%), Quality Score 60/100, from 11 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of CDEV calculated?
We run Cohen Dev through 11 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 158.87 ILA, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.9 % above its aggregate fair value. Cohen Dev currently trades 9 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Cohen Dev (CDEV)?
The closing price on Oct 8, 2026 was 145.30 ILA. Our model-based fair value is 158.87 ILA, about +9% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Cohen Dev right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. A fairly wide model range (96.14 ILA to 243.02 ILA) leaves room in how you read the outcome.
Where does the earnings growth of Cohen Dev (CDEV) come from?
Earnings per share at Cohen Dev grew +21.1 % a year from 2014 to 2025. Broken into its drivers: revenue per share +18.3 %, EBIT margin −0.4 %, tax rate +0.9 %, residual (interest, one-offs) +1.9 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of Cohen Dev

How large is the market capitalisation of Cohen Dev (CDEV)?
The market capitalisation of Cohen Dev is 1.1B ILA. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Cohen Dev (CDEV)?
The price-to-sales ratio of Cohen Dev is 13.1 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Cohen Dev (CDEV)?
Earnings per share at Cohen Dev are 12.73 ILA (price ÷ EPS = P/E 11.4). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Cohen Dev (CDEV)?
The dividend yield of Cohen Dev is 2.2% (payout 25.3%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Cohen Dev (CDEV)?
The net margin of Cohen Dev is 115% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Cohen Dev (CDEV)?
The return on equity (ROE) of Cohen Dev is 52.7% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Cohen Dev (CDEV)?
On an EBIT basis the return on assets of Cohen Dev is 65.3% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Cohen Dev (CDEV)?
The operating margin of Cohen Dev is 87.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Cohen Dev (CDEV)?
Revenue at Cohen Dev is growing +70.0% versus a year earlier (3y avg +11.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Cohen Dev (CDEV)?
Earnings per share at Cohen Dev are growing −24.3% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Cohen Dev (CDEV) hold?
Cohen Dev holds more cash than debt, 35.2M ILA net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Cohen Dev in the live analysis

One click puts Cohen Dev on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.